Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

Immune cells are crucial for hair growth and preventing hair loss.

Neoplasms hide in hair follicles to avoid the immune system.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Key genes and pathways crucial for hair follicle development in cashmere goats were identified, aiding fleece production improvement.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

The Skin POMC System affects hair growth and skin responses to stress.

Stress hormones and autoimmune reactions can cause hair loss.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Immune cells around hair follicles help control hair growth and could be targets for treating hair disorders.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Hair growth phase in mice weakens certain immune responses.

ILC1-like cells can independently cause alopecia areata.

Mesenchymal stem cell therapy may help treat alopecia areata by promoting hair growth and reducing inflammation.